In a move designed to strengthen its global patient diagnostics market, Danaher Corporation, a Washington-based science and technology firm, plans to merge operations with Masimo Corporation, a leading specialty diagnostics company headquartered in Irvine, California.
In its Feb. 17 announcement, Danaher said it will acquire all of Masimo’s outstanding shares of common stock for $180 per share in cash, carrying a total value of nearly $9.9 billion. The deal prices Masimo at nearly 18 times its estimated 2027 earnings before interest, taxes, depreciation, and amortization, according to Danaher.
